Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D001647:Bile Acids and Salts / Q000494:pharmacology; D001769:Blood / Q000382:microbiology; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002460:Cell Line; D003168:Complement Fixation Tests; D003429:Cross Reactions; D003588:Cytopathogenic Effect, Viral; D005260:Female; D005374:Filtration; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006571:Heterocyclic Compounds / Q000494:pharmacology; D006801:Humans; D007106:Immune Sera; D007668:Kidney; D007783:Lactones / Q000494:pharmacology; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D009549:Nigeria; D010614:Pharynx / Q000382:microbiology; D014556:Urine / Q000382:microbiology; D014776:Virus Cultivation; D014777:Virus Diseases / Q000382:microbiology*; D014779:Virus Replication; D014713:Viruses, Unclassified / Q000145:classification / Q000302:isolation & purification* / Q000472:pathogenicity
D000941:Antigens; D001647:Bile Acids and Salts; D006571:Heterocyclic Compounds; D007106:Immune Sera; D007783:Lactones; D001973:Bromodeoxyuridine